Buprenorphine and Prednisone: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Prednisone
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Let's talk about taking buprenorphine and prednisone together. Buprenorphine is broken down in your body by a liver enzyme called CYP3A4. Prednisone can speed up that enzyme, which means your body may clear the buprenorphine faster than usual. When that happens, there may be less buprenorphine working in your system, so it might not control your pain or cravings as well, and you could feel opioid withdrawal (things like chills, aches, sweating, or feeling anxious).
The good news is your care team can manage this. Please don't stop or change either medicine on your own. Just let your pharmacist or doctor know you take both, so they can keep an eye on how you feel and adjust things if needed.
Effect: Prednisone may induce CYP3A4, increasing buprenorphine metabolism and reducing its plasma exposure, potentially causing loss of efficacy and opioid withdrawal.
- Direction: Reduced buprenorphine effect (buprenorphine is the affected CYP3A4 substrate; not a relevant prodrug here).
- Evidence/onset: Probable; onset unspecified. Prednisone is a comparatively weak inducer, so clinical magnitude may be modest.
- Management: If the inducer is needed, consider titrating buprenorphine upward to stable effect and monitor for withdrawal. On inducer discontinuation, consider a buprenorphine dose reduction and monitor for respiratory depression. For subQ/long-acting formulations, verify adequate levels; transition to a formulation allowing precise titration if needed.
What happens
Reduced buprenorphine exposure and reduced efficacy of buprenorphine
Interaction Deep Dive
Because a CYP3A4 inducer can lower plasma levels of buprenorphine, taking the two together may bring on opioid withdrawal symptoms. When a patient on buprenorphine must start a CYP3A4 inducer, one option is to raise the buprenorphine dose until stable drug effects are reached, with monitoring for signs of withdrawal. Conversely, if a CYP3A4 inducer is stopped in someone receiving buprenorphine, consider lowering the buprenorphine dose and watch for respiratory depression2. Should dose adjustment prove impossible once the CYP3A4 inducer is gone, switch the patient back to a buprenorphine formulation that allows finer dose titration. For patients being converted from transmucosal buprenorphine given together with CYP3A4 inducers, confirm through monitoring that the plasma buprenorphine level delivered by subQ buprenorphine is sufficient. In those already established on subQ buprenorphine who then need a CYP3A4 inducer, monitor for withdrawal. When the buprenorphine dose is insufficient in the presence of the concomitant drug and that drug cannot be reduced or stopped, modify the buprenorphine dose. If the available doses cannot reach the target dose, treat the patient with a buprenorphine formulation that permits more precise dose adjustments1.
Why it happens (mechanism)
Induction of CYP3A4-mediated metabolism of buprenorphine
How to manage this interaction
Keep taking both medicines as prescribed unless your care team tells you otherwise. Here is what teams typically do:
- Watch for signs that buprenorphine may not be working as well, such as returning pain or withdrawal symptoms (aches, sweating, chills, restlessness).
- Your buprenorphine dose may be adjusted and individualized while you are on prednisone, and monitored more closely for stability.
- When prednisone is stopped, your team may lower the buprenorphine dose and watch for slowed or shallow breathing.
What to do: tell your pharmacist and prescriber you take both, and report any withdrawal symptoms or unusual drowsiness so they can fine-tune your care.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) The impact of a coadministered CYP3A4 inducer on buprenorphine exposure in patients receiving subcutaneous buprenorphine has not been investigated; nevertheless, such interactions have been demonstrated in studies employing transmucosal buprenorphine. Buprenorphine's effects may vary according to the route by which it is administered 1.
Common questions
Can I take Buprenorphine and Prednisone together?
Prednisone may lower buprenorphine levels and could trigger withdrawal or reduced effect; keep taking both as prescribed and tell your pharmacist or doctor so they can monitor you and adjust your dose if needed. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Buprenorphine and Prednisone interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Buprenorphine and Prednisone interaction managed?
Keep taking both medicines as prescribed unless your care team tells you otherwise. Here is what teams typically do: Watch for signs that buprenorphine may not be working as well, such as returning pain or withdrawal symptoms (aches, sweating, chills, restlessness). Your buprenorphine dose may be adjusted and individualized while you are on prednisone, and monitored more closely for stability. Whe… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Buprenorphine or Prednisone need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (2)
- Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
- Product Information: ZUBSOLV(R) sublingual tablets, buprenorphine naloxone sublingual tablets. Orexo US Inc (per FDA), Morristown, NJ, 2023. DailyMed
Keep reading about Buprenorphine
Keep reading about Prednisone
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist